These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1909706)

  • 1. Metabolic clearance of human follicle-stimulating hormone assessed by radioimmunoassay, immunoradiometric assay, and in vitro Sertoli cell bioassay.
    Urban RJ; Padmanabhan V; Beitins I; Veldhuis JD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):818-23. PubMed ID: 1909706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH.
    le Cotonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M
    Fertil Steril; 1994 Apr; 61(4):669-78. PubMed ID: 8150109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopotency in vitro and metabolic clearance rates of five pituitary preparations of follicle stimulating hormone.
    Phillips DJ; Hudson NL; Lun S; Condell LA; McNatty KP
    Reprod Fertil Dev; 1993; 5(2):181-90. PubMed ID: 8265802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics.
    le Contonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M
    Fertil Steril; 1994 Apr; 61(4):679-86. PubMed ID: 8150110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone.
    Zambrano E; Barrios-de-Tomasi J; Cárdenas M; Ulloa-Aguirre A
    Mol Hum Reprod; 1996 Aug; 2(8):563-71. PubMed ID: 9239668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative difference in follicle-stimulating hormone activity in the pituitaries of young women compared to that of men and elderly women.
    Wide L; Hobson BM
    J Clin Endocrinol Metab; 1983 Feb; 56(2):371-5. PubMed ID: 6401752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved in vitro bioassay for follicle-stimulating hormone (FSH): suitable for measurement of FSH in unextracted human serum.
    Padmanabhan V; Chappel SC; Beitins IZ
    Endocrinology; 1987 Sep; 121(3):1089-98. PubMed ID: 3113917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunoradiometric and bioactive follicle stimulating hormone secretion and clearance in young and elderly men during treatment with tamoxifen or flutamide.
    Urban RJ; Dahl KD; Lippert MC; Veldhuis JD
    J Androl; 1992; 13(6):579-86. PubMed ID: 1293137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive and specific in vitro bioassay method for the measurement of follicle-stimulating hormone activity.
    Van Damme MP; Robertson DM; Marana R; Ritzén EM; Diczfalusy E
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):224-37. PubMed ID: 463448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method.
    Jia XC; Hsueh AJ
    Endocrinology; 1986 Oct; 119(4):1570-7. PubMed ID: 2428600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Sertoli cell bioassay of follicle-stimulating hormone (FSH)-serum from different animal species alters the morphology of rat Sertoli cells without affecting their response to FSH.
    Simoni M; Schuhmann B; Weinbauer GF
    Gen Comp Endocrinol; 1994 Jul; 95(1):99-108. PubMed ID: 7926660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers.
    le Cotonnec JY; Porchet HC; Beltrami V; Howles C
    Hum Reprod; 1993 Oct; 8(10):1604-11. PubMed ID: 8300814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay.
    Jia XC; Kessel B; Yen SS; Tucker EM; Hsueh AJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1243-9. PubMed ID: 3084537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of diverse vertebrate gonadotropins on estradiol-17 beta formation in vitro in an immature rat Sertoli cell bioassay.
    Yu JY; Shen ST; Yang WH; Papkoff H; Ishii S
    Gen Comp Endocrinol; 1996 Nov; 104(2):253-61. PubMed ID: 8930616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of luteinizing hormone-releasing hormone on follicle-stimulating hormone-dependent responses in rat granulosa cells and Sertoli cells in vitro.
    Gore-Langton RE; Lacroix M; Dorrington JH
    Endocrinology; 1981 Mar; 108(3):812-9. PubMed ID: 6780324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific regulatory actions of dihydrotestosterone and estradiol on the dynamics of FSH secretion and clearance in humans.
    Urban RJ; Dahl KD; Padmanabhan V; Beitins IZ; Veldhuis JD
    J Androl; 1991; 12(1):27-35. PubMed ID: 1901308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects.
    Matikainen T; De Leeuw R; Mannaerts B; Huhtaniemi I
    Fertil Steril; 1994 Jan; 61(1):62-9. PubMed ID: 8293846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.